Comparison of the effects of high dose estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: An interim analysis of EORTC-GU group study no. 30865
- 20 December 1990
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 37 (6) , 971-975
- https://doi.org/10.1016/0960-0760(90)90452-q
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Mitomycin-C in the treatment of metastatic prostate cancer: report on an EORTC phase II studyWorld Journal of Urology, 1986
- High-Dose Medroxyprogesterone Acetate versus Prednisolone in Hormone-Resistant Prostatic CancerEuropean Urology, 1985
- Pharmacokinetics of estramustine phosphate (Estracyt®) in prostatic cancer patientsEuropean Journal of Clinical Pharmacology, 1984
- Growth and Cell Survival Following Treatment with Estramustine, Nor-Nitrogen Mustard, Estradiol and Testosterone of a Human Prostatic Cancer Cell Line (DU 145)Journal of Urology, 1982